Home
>
National Drug Code (NDC)
>
Strattera
Strattera - 0002-3251-30 - (Atomoxetine hydrochloride)
Drug Information of Strattera
| Product NDC: | 0002-3251 |
| Proprietary Name: | Strattera |
| Non Proprietary Name: | Atomoxetine hydrochloride |
| Active Ingredient(s): | 100 mg/1 & nbsp; Atomoxetine hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Strattera
| Product NDC: | 0002-3251 |
| Labeler Name: | Eli Lilly and Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021411 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20060301 |
Package Information of Strattera
| Package NDC: | 0002-3251-30 |
| Package Description: | 30 CAPSULE in 1 BOTTLE (0002-3251-30) |
NDC Information of Strattera
| NDC Code | 0002-3251-30 |
| Proprietary Name | Strattera |
| Package Description | 30 CAPSULE in 1 BOTTLE (0002-3251-30) |
| Product NDC | 0002-3251 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Atomoxetine hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20060301 |
| Marketing Category Name | NDA |
| Labeler Name | Eli Lilly and Company |
| Substance Name | ATOMOXETINE HYDROCHLORIDE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA] |
